{"text": "rt AT_USER $amgn amgen\u00a1\u00afs ph 3 news tonite is bad, estimates were for $800m+ or so, stock should be down $3-$5 on this"}
{"text": "rt AT_USER $amgn sees cardiovascular safety signal in romo arch trial- now doesn't expect approval in 2017 (prev pdufa july)"}
{"text": "rt AT_USER $amgn amgen\u00a1\u00afs ph 3 news tonite is bad, estimates were for $800m+ or so, stock should be down $3-$5 on this"}
{"text": "rt AT_USER $amgn amgen\u00a1\u00afs ph 3 news tonite is bad, estimates were for $800m+ or so, stock should be down $3-$5 on this"}
{"text": "rt AT_USER $amgn sees cardiovascular safety signal in romo arch trial- now doesn't expect approval in 2017 (prev pdufa july)"}
{"text": "AT_USER get ready tomorrow AT_USER  $amgn"}
{"text": "rt AT_USER $amgn amgen\u00a1\u00afs ph 3 news tonite is bad, estimates were for $800m+ or so, stock should be down $3-$5 on this"}
{"text": "$rdus good news for rdus after safety concerns on $amgn ph3 .."}
{"text": "rt AT_USER $amgn osteoporosis drug meets efficacy goals in ph3study, but new cv safety signal has evercore isi taking it out of model,\u00a1\u00ad"}
{"text": "rt AT_USER $amgn sees cardiovascular safety signal in romo arch trial- now doesn't expect approval in 2017 (prev pdufa july)"}
{"text": "rt AT_USER $amgn sees cardiovascular safety signal in romo arch trial- now doesn't expect approval in 2017 (prev pdufa july)"}
{"text": "rt AT_USER $amgn osteoporosis drug meets efficacy goals in ph3study, but new cv safety signal has evercore isi taking it out of model,\u00a1\u00ad"}
{"text": "megtirrell: $amgn osteoporosis drug meets efficacy goals in ph3study, but new cv safety signal has evercore isi taking it out of model, see\u00a1\u00ad"}
{"text": "rt AT_USER $amgn osteoporosis drug meets efficacy goals in ph3study, but new cv safety signal has evercore isi taking it out of model,\u00a1\u00ad"}
{"text": "rt AT_USER $amgn amgen\u00a1\u00afs ph 3 news tonite is bad, estimates were for $800m+ or so, stock should be down $3-$5 on this"}
{"text": "rt AT_USER $amgn sees cardiovascular safety signal in romo arch trial- now doesn't expect approval in 2017 (prev pdufa july)"}
{"text": "rt AT_USER $amgn sees cardiovascular safety signal in romo arch trial- now doesn't expect approval in 2017 (prev pdufa july)"}
{"text": "rt AT_USER $amgn amgen\u00a1\u00afs ph 3 news tonite is bad, estimates were for $800m+ or so, stock should be down $3-$5 on this"}
{"text": "rt AT_USER $amgn sees cardiovascular safety signal in romo arch trial- now doesn't expect approval in 2017 (prev pdufa july)"}
{"text": "$amgn amgen\u00a1\u00afs ph 3 news tonite is bad, estimates were for $800m+ or so, stock should be down $3-$5 on this"}
{"text": "rt AT_USER $amgn osteoporosis drug meets efficacy goals in ph3study, but new cv safety signal has evercore isi taking it out of model,\u00a1\u00ad"}
{"text": "rt AT_USER $amgn sees cardiovascular safety signal in romo arch trial- now doesn't expect approval in 2017 (prev pdufa july)"}
{"text": "$amgn osteoporosis drug meets efficacy goals in ph3study, but new cv safety signal has evercore isi taking it out of model, sees shrs -3-4%"}
{"text": "rt AT_USER $amgn sees cardiovascular safety signal in romo arch trial- now doesn't expect approval in 2017 (prev pdufa july)"}
{"text": "rt AT_USER $amgn sees cardiovascular safety signal in romo arch trial- now doesn't expect approval in 2017 (prev pdufa july)"}
{"text": "rt AT_USER $amgn sees cardiovascular safety signal in romo arch trial- now doesn't expect approval in 2017 (prev pdufa july)"}
{"text": "rt AT_USER $amgn sees cardiovascular safety signal in romo arch trial- now doesn't expect approval in 2017 (prev pdufa july)"}
{"text": "rt AT_USER $amgn sees cardiovascular safety signal in romo arch trial- now doesn't expect approval in 2017 (prev pdufa july)"}
{"text": "rt AT_USER $amgn sees cardiovascular safety signal in romo arch trial- now doesn't expect approval in 2017 (prev pdufa july)"}
{"text": "$amgn sees cardiovascular safety signal in romo arch trial- now doesn't expect approval in 2017 (prev pdufa july)"}
{"text": "higher rate of heart problems with #amgen osteoporosis drug in trial. read more: URL $amgn"}
{"text": "ucb : and #amgen announce top-line phase 3 data from ... read more: URL $amgn"}
{"text": "rt AT_USER the most important aspect of trading is not the stock pick but how you manage it. learn how in the splash zone $amgn URL"}
{"text": "rt AT_USER the most important aspect of trading is not the stock pick but how you manage it. learn how in the splash zone $amgn URL"}
{"text": "rt AT_USER the most important aspect of trading is not the stock pick but how you manage it. learn how in the splash zone $amgn URL"}
{"text": "rt AT_USER the most important aspect of trading is not the stock pick but how you manage it. learn how in the splash zone $amgn URL"}
{"text": "population pharmacokinetics and exposure\u00a8cresponse relationship of carfilzomib in patients w/ multiple myeloma $amgn URL"}
{"text": "impact of target-mediated elimination on the dose and regimen of evolocumab,a human mab against pcsk9 $amgn URL"}
{"text": "rt AT_USER the most important aspect of trading is not the stock pick but how you manage it. learn how in the splash zone $amgn URL"}
{"text": "rt AT_USER the most important aspect of trading is not the stock pick but how you manage it. learn how in the splash zone $amgn URL"}
{"text": "rt AT_USER the most important aspect of trading is not the stock pick but how you manage it. learn how in the splash zone $amgn URL"}
{"text": "rt AT_USER the most important aspect of trading is not the stock pick but how you manage it. learn how in the splash zone $amgn URL"}
{"text": "the most important aspect of trading is not the stock pick but how you manage it. learn how in the splash zone\u00a1\u00ad URL"}
{"text": "$amgn max pain is 157.50 for maturity 05/26/2017. prev close = 156.51.  URL URL"}
{"text": "$amgn stochastics oversold URL"}
{"text": "#allergan's editas plans have been delayed too! $agn $myl $mrk $gild $amgn $jazz $nvs $vrx $jnj  $teva $prgo $blue\u00a1\u00ad URL"}
{"text": "alta capital management llc reduces stake in amgen, inc. $amgn URL"}
{"text": "$amgn maturity 05/26/2017 vol putcallratio of 1.08 puts=818 calls=756 . URL URL"}
{"text": "amgen, inc. $amgn shares bought by nisa investment advisors llc URL"}
{"text": "amgen, inc. $amgn shares bought by nisa investment advisors llc URL"}
{"text": "rt AT_USER great news for pharma !! #botox doesn't treat everything!! hurrah! $vrx $agn $myl $mrk $twtr $gild $jazz $amgn $blue $exel\u00a1\u00ad"}
{"text": "will #allergan's audit committee do their job for the q2 filing? $agn $myl $mrk $teva $prgo $hlf $brk $iep $amgn\u00a1\u00ad URL"}
{"text": "great news for pharma !! #botox doesn't treat everything!! hurrah! $vrx $agn $myl $mrk $twtr $gild $jazz $amgn\u00a1\u00ad URL"}
{"text": "trust department mb financial bank n a continues to hold stake in amgen, inc. $amgn URL #stocks"}
{"text": "alta capital management llc reduces stake in amgen, inc. $amgn URL"}
{"text": "trust department mb financial bank n a continues to hold stake in amgen, inc. $amgn URL"}
{"text": "amgen, inc. $amgn shares bought by lederer &amp; associates investment counsel ca URL"}
{"text": "amgen, inc. $amgn shares bought by lederer &amp; associates investment counsel ca URL"}
{"text": "amgen, inc. $amgn position held by everence capital management inc. URL"}
{"text": "amgen, inc. $amgn position held by everence capital management inc. URL"}
{"text": "trust department mb financial bank n a continues to hold stake in amgen, inc. $amgn URL"}
{"text": "trust department mb financial bank n a continues to hold stake in amgen, inc. $amgn URL"}
{"text": "wondering about #sentiment indicator for $amgn? the short ratio is 1.76% URL"}
{"text": "not sure what to do with $amgn? explore our #fundamental pros and cons.  URL"}
{"text": "rt AT_USER $amgn files for approval of migraine prevention drug erenumab, partnered w $nvs"}
{"text": "rt AT_USER $acw every phase2 alzheimr drug has mkt capAT_USER actinigen, (asx:acw) is us$40m &amp;their drug works great. $lly,$pfe\u00a1\u00ad"}
{"text": "some #allergan shorts may have missed a ~10% decline $agn $myl $mrk $gild $jnj $amgn $acad $vrx $tsla $brk $tsro\u00a1\u00ad URL"}
{"text": "impressions count!  $agn $ibm $myl $bmy $brk $iep $amgn $jnj $ipxl $blue $twtr $vrx $sny $nvs $gild $eyes $catb\u00a1\u00ad URL"}
{"text": "impressions count!  $agn $ibm $myl $bmy $brk $iep $amgn $jnj $ipxl $blue $twtr $vrx $sny $nvs $gild $eyes $catb\u00a1\u00ad URL"}
{"text": "rt AT_USER i wonder why they sold?  $agn $vrx $prgo $jnj $gild $prgo $nvs $ebs $azn $amgn $acad $twtr $aapl $brk $iep $fb $snap $ibm $\u00a1\u00ad"}
{"text": "#allergan paid $ $agn $tst $myl $bmy $brk $iep $amgn $jnj $ipxl $blue $twtr $vrx $sny $nvs $gild $eyes $catb $trvn\u00a1\u00ad URL"}
{"text": "i wonder why they sold?  $agn $vrx $prgo $jnj $gild $prgo $nvs $ebs $azn $amgn $acad $twtr $aapl $brk $iep $fb\u00a1\u00ad URL"}
{"text": "is #allergan fudging their diluted share count? $agn $vrx $prgo $tst $jnj $gild $prgo $nvs $ebs $azn $amgn $acad\u00a1\u00ad URL"}
{"text": "george bennett rides to victory in pasadena at the 2017 #amgen tour of california. read more: URL $amgn"}
{"text": "george bennett rides to victory in pasadena at the 2017 #amgen tour of california. read more: URL $amgn"}
{"text": "$amgn high open interest range is 155.00 to 160.00 for option expiration 05/26/2017. URL URL"}
{"text": "rt AT_USER $kite $juno $celg $ziop $amgn no other cart-t research biotech has the safety profile that $tgtx has, increased infusion rat\u00a1\u00ad"}
